Advanced search
Publication Cover
Ophthalmic Genetics Volume 43, 2022 - Issue 6: Special Issue: Festschrift: Dedicated to the life and work of A. Linn Murphree, MD
Submit an article Journal homepage
1,782
Views
3
CrossRef citations to date
0
Altmetric
Reviews

Cell Free DNA (cfDNA) in the Blood of Retinoblastoma Patients The Robert M. Ellsworth Lecture

David H. Abramsona Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA;b Department of Ophthalmology, Weill Cornell Medical School, New York, New York, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0118-6391View further author information
ORCID Icon
Pages 731-735 | Received 16 Sep 2021, Accepted 05 Nov 2021, Published online: 05 Apr 2022

References

  • Corcoran RB, Chabner BA. Application of Cell-free DNA analysis to cancer treatment. N Engl J Med. 2018;379(18):1754–65. doi:10.1056/NEJMra1706174.
  • Brannon AR, Jayakumaran G, Diosdado M, Patel J, Razumova A, Hu Y, Meng F, Haque M, Sadowska J, et al. Enhanced specificity of high sensitivity somatic variant profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS. Nat Commun. 2021;12(3770). https://doi.org/10.1038/s41467-021-24109-5
  • Kothari P, Marass F, Yang JL, Stewart CM, Stephens D, Patel J, Hasan M, Jing X, Meng F, Enriquez J, et al. Cell-free DNA profiling in retinoblastoma patients with advanced intraocular disease: an MSKCC experience. Cancer Med. 2020;9(17):6093–101. doi:10.1002/cam4.3144.
  • Abramson DH, Mandelker D, Francis JH, Dunkel IJ, Brannon AR, Benayed R, Berger MF, Arcila ME, Ladanyi M, Friedman DN, et al. Retrospective evaluation of somatic alterations in Cell-Free DNA from blood in retinoblastoma. Ophthalmol Sci. 2021;1(1):100015. doi:10.1016/j.xops.2021.100015.
  • Fiala C, Diamandis EP. Cell-free DNA analysis in cancer. N Engl J Med. 2019;380(5):501.
  • Lu JE, Francis JH, Dunkel IJ, Shields CL, Yu MD, Berry JL, Kogachi K, Skalet AH, Miller AK, Santapuram PR, et al. Metastases and death rates after primary enucleation of unilateral retinoblastoma in the USA 2007-2017. Br J Ophthalmol. 2019;103(9):1272–77. doi:10.1136/bjophthalmol-2018-312915.
  • Francis JH, Gobin YP, Brannon AR, Swartzwelder CE, Berger MF, Mandelker DL, Walsh MF, Dunkel IJ, Abramson DH. RB1 circulating tumor DNA in the blood of patients with unilateral retinoblastoma: before and after intra-arterial chemotherapy. Ophthalmol Sci. 2021;1(3). doi:10.1016/j.xops.2021.100042.
  • Abramson DH, Ellsworth RM, Zimmerman LE. Nonocular cancer in retinoblastoma survivors. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1976;81(3 Pt 1):454–57.
  • Eng C, Li FP, Abramson DH, Ellsworth RM, Wong FL, Goldman MB, Seddon J, Tarbell N, Boice JD. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst. 1993;85(14):1121–28. doi:10.1093/jnci/85.14.1121.
  • Abramson DH. Second nonocular cancers in retinoblastoma: a unified hypothesis the franceschetti lecture. Ophthalmic Genet. 1999;20(3):193–204. doi:10.1076/opge.20.3.193.2284.
  • Friedman DN, Hsu M, Moskowitz CS, Francis JH, Lis E, Fleischut MH, Oeffinger KC, Walsh M, Tonorezos ES, Sklar CA, et al. Whole-body magnetic resonance imaging as surveillance for subsequent malignancies in preadolescent, adolescent, and young adult survivors of germline retinoblastoma: an update. Pediatr Blood Cancer. 2020;67(7):e28389. doi:10.1002/pbc.28389.
  • Fiala EM, Jayakumaran G, Mauguen A, Kennedy JA, Bouvier N, Kemel Y, Fleischut MH, Maio A, Salo-Mullen EE, Sheehan M, et al. Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors. Nat Cancer. 2021;2:357–65.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.